aluates Reports

$ 0.0

Automative

Global MHC-Peptide Tetramer Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-24H18276

Global MHC Peptide Tetramer Market Research Report 2024

BUY CHAPTERS

Global MHC-Peptide Tetramer Market Research Report 2025

Code: QYRE-Auto-24H18276

Report

February 2025

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Creative-Biolabs

ACROBiosystems

Proimmune

immunAware

MedChemExpress (MCE)

WuXi AppTec

KACTUS

ChemPartner

BioLegend (Revvity)

MBL Life Science (JSR Corporation)

Creative Biosciences

MHC-Peptide Tetramer Market Size

The global market for MHC-Peptide Tetramer was valued at US$ 194 million in the year 2024 and is projected to reach a revised size of US$ 382 million by 2031, growing at a CAGR of 10.5% during the forecast period.

MHC-Peptide Tetramer Market

An MHC tetramer is a laboratory tool used to study antigen-specific T cells. It consists of four major histocompatibility complex (MHC) molecules bound to a specific peptide and labeled with a fluorescent tag. These tetramers can bind to T cell receptors (TCRs) on the surface of T cells that recognize the specific peptide-MHC complex. By using flow cytometry, researchers can identify and quantify antigen-specific T cells, making MHC tetramers a valuable tool for immunological studies, including vaccine development, cancer immunotherapy, and infectious disease research.

Increased focus on cancer immunotherapy and adoptive T cell therapies is driving demand for MHC tetramers to study antigen-specific T cell responses.

This report aims to provide a comprehensive presentation of the global market for MHC-Peptide Tetramer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MHC-Peptide Tetramer.

The MHC-Peptide Tetramer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global MHC-Peptide Tetramer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the MHC-Peptide Tetramer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of MHC-Peptide Tetramer Market Report

Report Metric	Details
Report Name	MHC-Peptide Tetramer Market
Accounted market size in year	US$ 194 million
Forecasted market size in 2031	US$ 382 million
CAGR	10.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	MHC-I MHC-II
Segment by Application	Infectious Disease Research Cancer Immunology Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioLegend (Revvity), MBL Life Science (JSR Corporation), ImmunAware, ProImmune, MedChemExpress (MCE), Creative Biolabs, WuXi AppTec, KACTUS, Creative Biosciences, ACROBiosystems, ChemPartner
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of MHC-Peptide Tetramer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is MHC-Peptide Tetramer Market growing?

Ans: The MHC-Peptide Tetramer Market witnessing a CAGR of 10.5% during the forecast period 2025-2031.

What is the MHC-Peptide Tetramer Market size in 2031?

Ans: The MHC-Peptide Tetramer Market size in 2031 will be US$ 382 million.

Who are the main players in the MHC-Peptide Tetramer Market report?

Ans: The main players in the MHC-Peptide Tetramer Market are BioLegend (Revvity), MBL Life Science (JSR Corporation), ImmunAware, ProImmune, MedChemExpress (MCE), Creative Biolabs, WuXi AppTec, KACTUS, Creative Biosciences, ACROBiosystems, ChemPartner

What are the Application segmentation covered in the MHC-Peptide Tetramer Market report?

Ans: The Applications covered in the MHC-Peptide Tetramer Market report are Infectious Disease Research, Cancer Immunology, Other

What are the Type segmentation covered in the MHC-Peptide Tetramer Market report?

Ans: The Types covered in the MHC-Peptide Tetramer Market report are MHC-I, MHC-II

Recommended Reports

T-Cell Therapies

Peptide Markets

Immunology & Cytometry

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global MHC-Peptide Tetramer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 MHC-I

1.2.3 MHC-II

1.3 Market by Application

1.3.1 Global MHC-Peptide Tetramer Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Infectious Disease Research

1.3.3 Cancer Immunology

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global MHC-Peptide Tetramer Market Perspective (2020-2031)

2.2 Global MHC-Peptide Tetramer Growth Trends by Region

2.2.1 Global MHC-Peptide Tetramer Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 MHC-Peptide Tetramer Historic Market Size by Region (2020-2025)

2.2.3 MHC-Peptide Tetramer Forecasted Market Size by Region (2026-2031)

2.3 MHC-Peptide Tetramer Market Dynamics

2.3.1 MHC-Peptide Tetramer Industry Trends

2.3.2 MHC-Peptide Tetramer Market Drivers

2.3.3 MHC-Peptide Tetramer Market Challenges

2.3.4 MHC-Peptide Tetramer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top MHC-Peptide Tetramer Players by Revenue

3.1.1 Global Top MHC-Peptide Tetramer Players by Revenue (2020-2025)

3.1.2 Global MHC-Peptide Tetramer Revenue Market Share by Players (2020-2025)

3.2 Global Top MHC-Peptide Tetramer Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by MHC-Peptide Tetramer Revenue

3.4 Global MHC-Peptide Tetramer Market Concentration Ratio

3.4.1 Global MHC-Peptide Tetramer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by MHC-Peptide Tetramer Revenue in 2024

3.5 Global Key Players of MHC-Peptide Tetramer Head office and Area Served

3.6 Global Key Players of MHC-Peptide Tetramer, Product and Application

3.7 Global Key Players of MHC-Peptide Tetramer, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 MHC-Peptide Tetramer Breakdown Data by Type

4.1 Global MHC-Peptide Tetramer Historic Market Size by Type (2020-2025)

4.2 Global MHC-Peptide Tetramer Forecasted Market Size by Type (2026-2031)

5 MHC-Peptide Tetramer Breakdown Data by Application

5.1 Global MHC-Peptide Tetramer Historic Market Size by Application (2020-2025)

5.2 Global MHC-Peptide Tetramer Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America MHC-Peptide Tetramer Market Size (2020-2031)

6.2 North America MHC-Peptide Tetramer Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America MHC-Peptide Tetramer Market Size by Country (2020-2025)

6.4 North America MHC-Peptide Tetramer Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe MHC-Peptide Tetramer Market Size (2020-2031)

7.2 Europe MHC-Peptide Tetramer Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe MHC-Peptide Tetramer Market Size by Country (2020-2025)

7.4 Europe MHC-Peptide Tetramer Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific MHC-Peptide Tetramer Market Size (2020-2031)

8.2 Asia-Pacific MHC-Peptide Tetramer Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific MHC-Peptide Tetramer Market Size by Region (2020-2025)

8.4 Asia-Pacific MHC-Peptide Tetramer Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America MHC-Peptide Tetramer Market Size (2020-2031)

9.2 Latin America MHC-Peptide Tetramer Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America MHC-Peptide Tetramer Market Size by Country (2020-2025)

9.4 Latin America MHC-Peptide Tetramer Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa MHC-Peptide Tetramer Market Size (2020-2031)

10.2 Middle East & Africa MHC-Peptide Tetramer Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa MHC-Peptide Tetramer Market Size by Country (2020-2025)

10.4 Middle East & Africa MHC-Peptide Tetramer Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BioLegend (Revvity)

11.1.1 BioLegend (Revvity) Company Details

11.1.2 BioLegend (Revvity) Business Overview

11.1.3 BioLegend (Revvity) MHC-Peptide Tetramer Introduction

11.1.4 BioLegend (Revvity) Revenue in MHC-Peptide Tetramer Business (2020-2025)

11.1.5 BioLegend (Revvity) Recent Development

11.2 MBL Life Science (JSR Corporation)

11.2.1 MBL Life Science (JSR Corporation) Company Details

11.2.2 MBL Life Science (JSR Corporation) Business Overview

11.2.3 MBL Life Science (JSR Corporation) MHC-Peptide Tetramer Introduction

11.2.4 MBL Life Science (JSR Corporation) Revenue in MHC-Peptide Tetramer Business (2020-2025)

11.2.5 MBL Life Science (JSR Corporation) Recent Development

11.3 ImmunAware

11.3.1 ImmunAware Company Details

11.3.2 ImmunAware Business Overview

11.3.3 ImmunAware MHC-Peptide Tetramer Introduction

11.3.4 ImmunAware Revenue in MHC-Peptide Tetramer Business (2020-2025)

11.3.5 ImmunAware Recent Development

11.4 ProImmune

11.4.1 ProImmune Company Details

11.4.2 ProImmune Business Overview

11.4.3 ProImmune MHC-Peptide Tetramer Introduction

11.4.4 ProImmune Revenue in MHC-Peptide Tetramer Business (2020-2025)

11.4.5 ProImmune Recent Development

11.5 MedChemExpress (MCE)

11.5.1 MedChemExpress (MCE) Company Details

11.5.2 MedChemExpress (MCE) Business Overview

11.5.3 MedChemExpress (MCE) MHC-Peptide Tetramer Introduction

11.5.4 MedChemExpress (MCE) Revenue in MHC-Peptide Tetramer Business (2020-2025)

11.5.5 MedChemExpress (MCE) Recent Development

11.6 Creative Biolabs

11.6.1 Creative Biolabs Company Details

11.6.2 Creative Biolabs Business Overview

11.6.3 Creative Biolabs MHC-Peptide Tetramer Introduction

11.6.4 Creative Biolabs Revenue in MHC-Peptide Tetramer Business (2020-2025)

11.6.5 Creative Biolabs Recent Development

11.7 WuXi AppTec

11.7.1 WuXi AppTec Company Details

11.7.2 WuXi AppTec Business Overview

11.7.3 WuXi AppTec MHC-Peptide Tetramer Introduction

11.7.4 WuXi AppTec Revenue in MHC-Peptide Tetramer Business (2020-2025)

11.7.5 WuXi AppTec Recent Development

11.8 KACTUS

11.8.1 KACTUS Company Details

11.8.2 KACTUS Business Overview

11.8.3 KACTUS MHC-Peptide Tetramer Introduction

11.8.4 KACTUS Revenue in MHC-Peptide Tetramer Business (2020-2025)

11.8.5 KACTUS Recent Development

11.9 Creative Biosciences

11.9.1 Creative Biosciences Company Details

11.9.2 Creative Biosciences Business Overview

11.9.3 Creative Biosciences MHC-Peptide Tetramer Introduction

11.9.4 Creative Biosciences Revenue in MHC-Peptide Tetramer Business (2020-2025)

11.9.5 Creative Biosciences Recent Development

11.10 ACROBiosystems

11.10.1 ACROBiosystems Company Details

11.10.2 ACROBiosystems Business Overview

11.10.3 ACROBiosystems MHC-Peptide Tetramer Introduction

11.10.4 ACROBiosystems Revenue in MHC-Peptide Tetramer Business (2020-2025)

11.10.5 ACROBiosystems Recent Development

11.11 ChemPartner

11.11.1 ChemPartner Company Details

11.11.2 ChemPartner Business Overview

11.11.3 ChemPartner MHC-Peptide Tetramer Introduction

11.11.4 ChemPartner Revenue in MHC-Peptide Tetramer Business (2020-2025)

11.11.5 ChemPartner Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Creative-Biolabs

ACROBiosystems

Proimmune

immunAware

MedChemExpress (MCE)

WuXi AppTec

KACTUS

ChemPartner

BioLegend (Revvity)

MBL Life Science (JSR Corporation)

Creative Biosciences

List of Tables

Table 1. Global MHC-Peptide Tetramer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of MHC-I

Table 3. Key Players of MHC-II

Table 4. Global MHC-Peptide Tetramer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global MHC-Peptide Tetramer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global MHC-Peptide Tetramer Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global MHC-Peptide Tetramer Market Share by Region (2020-2025)

Table 8. Global MHC-Peptide Tetramer Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global MHC-Peptide Tetramer Market Share by Region (2026-2031)

Table 10. MHC-Peptide Tetramer Market Trends

Table 11. MHC-Peptide Tetramer Market Drivers

Table 12. MHC-Peptide Tetramer Market Challenges

Table 13. MHC-Peptide Tetramer Market Restraints

Table 14. Global MHC-Peptide Tetramer Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global MHC-Peptide Tetramer Market Share by Players (2020-2025)

Table 16. Global Top MHC-Peptide Tetramer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MHC-Peptide Tetramer as of 2024)

Table 17. Ranking of Global Top MHC-Peptide Tetramer Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by MHC-Peptide Tetramer Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of MHC-Peptide Tetramer, Headquarters and Area Served

Table 20. Global Key Players of MHC-Peptide Tetramer, Product and Application

Table 21. Global Key Players of MHC-Peptide Tetramer, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global MHC-Peptide Tetramer Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global MHC-Peptide Tetramer Revenue Market Share by Type (2020-2025)

Table 25. Global MHC-Peptide Tetramer Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global MHC-Peptide Tetramer Revenue Market Share by Type (2026-2031)

Table 27. Global MHC-Peptide Tetramer Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global MHC-Peptide Tetramer Revenue Market Share by Application (2020-2025)

Table 29. Global MHC-Peptide Tetramer Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global MHC-Peptide Tetramer Revenue Market Share by Application (2026-2031)

Table 31. North America MHC-Peptide Tetramer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America MHC-Peptide Tetramer Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America MHC-Peptide Tetramer Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe MHC-Peptide Tetramer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe MHC-Peptide Tetramer Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe MHC-Peptide Tetramer Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific MHC-Peptide Tetramer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific MHC-Peptide Tetramer Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific MHC-Peptide Tetramer Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America MHC-Peptide Tetramer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America MHC-Peptide Tetramer Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America MHC-Peptide Tetramer Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa MHC-Peptide Tetramer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa MHC-Peptide Tetramer Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa MHC-Peptide Tetramer Market Size by Country (2026-2031) & (US$ Million)

Table 46. BioLegend (Revvity) Company Details

Table 47. BioLegend (Revvity) Business Overview

Table 48. BioLegend (Revvity) MHC-Peptide Tetramer Product

Table 49. BioLegend (Revvity) Revenue in MHC-Peptide Tetramer Business (2020-2025) & (US$ Million)

Table 50. BioLegend (Revvity) Recent Development

Table 51. MBL Life Science (JSR Corporation) Company Details

Table 52. MBL Life Science (JSR Corporation) Business Overview

Table 53. MBL Life Science (JSR Corporation) MHC-Peptide Tetramer Product

Table 54. MBL Life Science (JSR Corporation) Revenue in MHC-Peptide Tetramer Business (2020-2025) & (US$ Million)

Table 55. MBL Life Science (JSR Corporation) Recent Development

Table 56. ImmunAware Company Details

Table 57. ImmunAware Business Overview

Table 58. ImmunAware MHC-Peptide Tetramer Product

Table 59. ImmunAware Revenue in MHC-Peptide Tetramer Business (2020-2025) & (US$ Million)

Table 60. ImmunAware Recent Development

Table 61. ProImmune Company Details

Table 62. ProImmune Business Overview

Table 63. ProImmune MHC-Peptide Tetramer Product

Table 64. ProImmune Revenue in MHC-Peptide Tetramer Business (2020-2025) & (US$ Million)

Table 65. ProImmune Recent Development

Table 66. MedChemExpress (MCE) Company Details

Table 67. MedChemExpress (MCE) Business Overview

Table 68. MedChemExpress (MCE) MHC-Peptide Tetramer Product

Table 69. MedChemExpress (MCE) Revenue in MHC-Peptide Tetramer Business (2020-2025) & (US$ Million)

Table 70. MedChemExpress (MCE) Recent Development

Table 71. Creative Biolabs Company Details

Table 72. Creative Biolabs Business Overview

Table 73. Creative Biolabs MHC-Peptide Tetramer Product

Table 74. Creative Biolabs Revenue in MHC-Peptide Tetramer Business (2020-2025) & (US$ Million)

Table 75. Creative Biolabs Recent Development

Table 76. WuXi AppTec Company Details

Table 77. WuXi AppTec Business Overview

Table 78. WuXi AppTec MHC-Peptide Tetramer Product

Table 79. WuXi AppTec Revenue in MHC-Peptide Tetramer Business (2020-2025) & (US$ Million)

Table 80. WuXi AppTec Recent Development

Table 81. KACTUS Company Details

Table 82. KACTUS Business Overview

Table 83. KACTUS MHC-Peptide Tetramer Product

Table 84. KACTUS Revenue in MHC-Peptide Tetramer Business (2020-2025) & (US$ Million)

Table 85. KACTUS Recent Development

Table 86. Creative Biosciences Company Details

Table 87. Creative Biosciences Business Overview

Table 88. Creative Biosciences MHC-Peptide Tetramer Product

Table 89. Creative Biosciences Revenue in MHC-Peptide Tetramer Business (2020-2025) & (US$ Million)

Table 90. Creative Biosciences Recent Development

Table 91. ACROBiosystems Company Details

Table 92. ACROBiosystems Business Overview

Table 93. ACROBiosystems MHC-Peptide Tetramer Product

Table 94. ACROBiosystems Revenue in MHC-Peptide Tetramer Business (2020-2025) & (US$ Million)

Table 95. ACROBiosystems Recent Development

Table 96. ChemPartner Company Details

Table 97. ChemPartner Business Overview

Table 98. ChemPartner MHC-Peptide Tetramer Product

Table 99. ChemPartner Revenue in MHC-Peptide Tetramer Business (2020-2025) & (US$ Million)

Table 100. ChemPartner Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. MHC-Peptide Tetramer Picture

Figure 2. Global MHC-Peptide Tetramer Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global MHC-Peptide Tetramer Market Share by Type: 2024 VS 2031

Figure 4. MHC-I Features

Figure 5. MHC-II Features

Figure 6. Global MHC-Peptide Tetramer Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global MHC-Peptide Tetramer Market Share by Application: 2024 VS 2031

Figure 8. Infectious Disease Research Case Studies

Figure 9. Cancer Immunology Case Studies

Figure 10. Other Case Studies

Figure 11. MHC-Peptide Tetramer Report Years Considered

Figure 12. Global MHC-Peptide Tetramer Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global MHC-Peptide Tetramer Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global MHC-Peptide Tetramer Market Share by Region: 2024 VS 2031

Figure 15. Global MHC-Peptide Tetramer Market Share by Players in 2024

Figure 16. Global MHC-Peptide Tetramer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by MHC-Peptide Tetramer Revenue in 2024

Figure 18. North America MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America MHC-Peptide Tetramer Market Share by Country (2020-2031)

Figure 20. United States MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe MHC-Peptide Tetramer Market Share by Country (2020-2031)

Figure 24. Germany MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific MHC-Peptide Tetramer Market Share by Region (2020-2031)

Figure 32. China MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America MHC-Peptide Tetramer Market Share by Country (2020-2031)

Figure 40. Mexico MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa MHC-Peptide Tetramer Market Share by Country (2020-2031)

Figure 44. Turkey MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE MHC-Peptide Tetramer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. BioLegend (Revvity) Revenue Growth Rate in MHC-Peptide Tetramer Business (2020-2025)

Figure 48. MBL Life Science (JSR Corporation) Revenue Growth Rate in MHC-Peptide Tetramer Business (2020-2025)

Figure 49. ImmunAware Revenue Growth Rate in MHC-Peptide Tetramer Business (2020-2025)

Figure 50. ProImmune Revenue Growth Rate in MHC-Peptide Tetramer Business (2020-2025)

Figure 51. MedChemExpress (MCE) Revenue Growth Rate in MHC-Peptide Tetramer Business (2020-2025)

Figure 52. Creative Biolabs Revenue Growth Rate in MHC-Peptide Tetramer Business (2020-2025)

Figure 53. WuXi AppTec Revenue Growth Rate in MHC-Peptide Tetramer Business (2020-2025)

Figure 54. KACTUS Revenue Growth Rate in MHC-Peptide Tetramer Business (2020-2025)

Figure 55. Creative Biosciences Revenue Growth Rate in MHC-Peptide Tetramer Business (2020-2025)

Figure 56. ACROBiosystems Revenue Growth Rate in MHC-Peptide Tetramer Business (2020-2025)

Figure 57. ChemPartner Revenue Growth Rate in MHC-Peptide Tetramer Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drugs Based on CAR T cell Market Research Report 2025

Global CAR T cell Therapy Drug Market Research Report 2025

Global T Cell Isolation Kit Market Research Report 2024

Global T Cell Activation Kit Market Research Report 2024

Global TCR Based Antibody Market Research Report 2025

Global Drug based on CAR T Cell Market Research Report 2025

Global Biologics Targeting CCR4 Market Research Report 2024

Global CAR T Cell Therapy Agents Market Research Report 2025

Peptide Synthesis Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lectin Array Kits Market Research Report 2024

Global MHC Tetramers Market Research Report 2025

Global MHC Monomers Tetramers Market Research Report 2024

Global Multiple Antigenic Peptides MAP Market Research Report 2024

Global MHC peptide Complexes Market Research Report 2024

Global Cytotoxic T Cells CTL Market Research Report 2024

Global Automatic Peptide Synthesis Equipment Market Insights Forecast to 2030

CAR T Cell Based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Peptide Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global T Cell Magnetic Beads Isolation Kit Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions